APEX1 and Alzheimer disease: Moreover, in another study, CDK5-dependent phosphorylation of APE1 at Thr232 suppressed the activity of APE1 in the AD brain [77], suggesting that the activity of APE1 is diminished by abnormal protein modification in AD.